ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,900.23
0.54%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Inhibrx Inc (INBX)

  7. Inhibrx Inc (INBX) News

Inhibrx (INBX)

Inhibrx Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INBX
DateTimeSourceHeadlineSymbolCompany
24/05/202423:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Inc
24/05/202421:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:INBXInhibrx Inc
24/05/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
24/05/202421:00PR Newswire (US)Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to SanofiNASDAQ:INBXInhibrx Inc
22/05/202414:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
21/05/202402:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Inc
17/05/202422:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
17/05/202421:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Inc
10/05/202423:36PR Newswire (US)Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-OffNASDAQ:INBXInhibrx Inc
09/05/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
08/05/202421:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Inc
08/05/202421:42Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
08/05/202421:37PR Newswire (US)Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated MergerNASDAQ:INBXInhibrx Inc
06/05/202422:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
11/03/202420:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
08/03/202421:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
08/03/202420:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
06/03/202421:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INBXInhibrx Inc
05/03/202419:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
04/03/202423:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INBXInhibrx Inc
29/02/202422:26Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:INBXInhibrx Inc
28/02/202414:15PR Newswire (US)Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:INBXInhibrx Inc
28/02/202414:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
28/02/202414:10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INBXInhibrx Inc
14/02/202421:12Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBXInhibrx Inc
06/02/202421:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Inc
26/01/202417:12PR Newswire (US)Kuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to Contact Law FirmNASDAQ:INBXInhibrx Inc
23/01/202422:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Inc
23/01/202411:38Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Inc
23/01/202411:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Inc
 Showing the most relevant articles for your search:NASDAQ:INBX

Your Recent History

LSE
ENET
Ethernity Networks
LSE
NG.
National Grid
LSE
ZED
Zenova
LSE
POS
Plexus
LSE
LLOY
Lloyds Banking
LSE
AAZ
Anglo Asian Mining
LSE
SCLP
Scancell
LSE
SOS
Sosandar
LSE
NFDS
Northern Foods
LSE
KEFI
Kefi Gold And Copper
LSE
VLX
Volex
LSE
TXP
Touchstone Exploration
LSE
AVAP
Avation
LSE
CLDN
Caledonia Investments
NASDAQ
SBLK
Star Bulk Carriers
LSE
TERN
Tern
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved